{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T06:18:07Z","timestamp":1766902687158,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BU 1141\/13-1"],"award-info":[{"award-number":["BU 1141\/13-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The acute-phase protein pentraxin-3 (PTX3) is a component of the innate immune system. Inflammation and tissue injury increased PTX3 in the injured liver, and accordingly, circulating PTX3 was induced in patients with chronic liver diseases. In the present study, PTX3 protein was determined in systemic, hepatic, and portal vein plasma of patients with liver cirrhosis to assess a possible association between hepatic PTX3 release and extent of liver injury. However, PTX3 levels were not related to disease severity. Of note, portal PTX3 levels were higher than concentrations in the hepatic vein. PTX3 in the hepatic and portal veins was negatively correlated with factor V, antithrombin 3, and prothrombin time. PTX3 did neither correlate with C-reactive protein nor galectin-3 or resistin, whereby the latter two proteins are associated with hepatic injury. PTX3 levels were not changed in cirrhosis patients with ascites or varices and did not correlate with the hepatic venous pressure gradient. Likewise, serum PTX3 was not correlated with histological steatosis, inflammation, or fibrosis stage in patients with hepatocellular carcinoma (HCC). Moreover, PTX3 was not associated with tumor node metastasis classification in HCC. Above all, PTX3 increased in hepatic, portal, and systemic blood immediately after transjugular intrahepatic portosystemic shunt (TIPS). Higher PTX3 in portal than hepatic vein plasma and further increase after TIPS suggests that the liver eliminates PTX3 from the circulation. In summary, PTX3 is not of diagnostic value in cirrhosis and HCC patients.<\/jats:p>","DOI":"10.1007\/s10238-020-00617-4","type":"journal-article","created":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T16:02:48Z","timestamp":1582214568000},"page":"289-297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients"],"prefix":"10.1007","volume":"20","author":[{"given":"Susanne","family":"Feder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth M.","family":"Haberl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlen","family":"Spirk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas S.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiner","family":"Wiest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5635-3994","authenticated-orcid":false,"given":"Christa","family":"Buechler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,20]]},"reference":[{"issue":"2","key":"617_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.bpg.2011.02.009","volume":"25","author":"M Pinzani","year":"2011","unstructured":"Pinzani M, Rosselli M, Zuckermann M. Liver cirrhosis. Best Pract Res Clin Gastroenterol. 2011;25(2):281\u201390. https:\/\/doi.org\/10.1016\/j.bpg.2011.02.009.","journal-title":"Best Pract Res Clin Gastroenterol."},{"issue":"18","key":"617_CR2","doi-asserted-by":"publisher","first-page":"5442","DOI":"10.3748\/wjg.v20.i18.5442","volume":"20","author":"S Nusrat","year":"2014","unstructured":"Nusrat S, Khan MS, Fazili J, Madhoun MF. Cirrhosis and its complications: evidence based treatment. World J Gastroenterol. 2014;20(18):5442\u201360. https:\/\/doi.org\/10.3748\/wjg.v20.i18.5442.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"617_CR3","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1478-3231.2005.01163.x","volume":"25","author":"W Laleman","year":"2005","unstructured":"Laleman W, Landeghem L, Wilmer A, Fevery J, Nevens F. Portal hypertension: from pathophysiology to clinical practice. Liver Int. 2005;25(6):1079\u201390. https:\/\/doi.org\/10.1111\/j.1478-3231.2005.01163.x.","journal-title":"Liver Int"},{"issue":"45","key":"617_CR4","doi-asserted-by":"publisher","first-page":"16996","DOI":"10.3748\/wjg.v20.i45.16996","volume":"20","author":"S Siramolpiwat","year":"2014","unstructured":"Siramolpiwat S. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications. World J Gastroenterol. 2014;20(45):16996\u20137010. https:\/\/doi.org\/10.3748\/wjg.v20.i45.16996.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"617_CR5","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1055\/s-0037-1614559","volume":"81","author":"S Basili","year":"1999","unstructured":"Basili S, Merli M, Ferro D, Lionetti R, Rossi E, Riggio O, et al. Clotting activation after transjugular intrahepatic portosystemic stent shunt. Thromb Haemost. 1999;81(5):711\u20134.","journal-title":"Thromb Haemost"},{"key":"617_CR6","first-page":"24","volume":"8","author":"A De Santis","year":"2016","unstructured":"De Santis A, Iegri C, Fagiuoli S. TIPS and HCC: friends or foes? Imaging Med. 2016;8:24\u20139.","journal-title":"Imaging Med"},{"issue":"1","key":"617_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10875-007-9126-7","volume":"28","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Garlanda C, Doni A, Bottazzi B. Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. J Clin Immunol. 2008;28(1):1\u201313. https:\/\/doi.org\/10.1007\/s10875-007-9126-7.","journal-title":"J Clin Immunol"},{"issue":"2","key":"617_CR8","first-page":"113","volume":"27","author":"G Pieri","year":"2014","unstructured":"Pieri G, Agarwal B, Burroughs AK. C-reactive protein and bacterial infection in cirrhosis. Ann Gastroenterol. 2014;27(2):113\u201320.","journal-title":"Ann Gastroenterol"},{"issue":"1","key":"617_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/imr.12570","volume":"280","author":"M Erreni","year":"2017","unstructured":"Erreni M, Manfredi AA, Garlanda C, Mantovani A, Rovere-Querini P. The long pentraxin PTX3: a prototypical sensor of tissue injury and a regulator of homeostasis. Immunol Rev. 2017;280(1):112\u201325. https:\/\/doi.org\/10.1111\/imr.12570.","journal-title":"Immunol Rev"},{"issue":"6","key":"617_CR10","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1084\/jem.20141268","volume":"212","author":"A Doni","year":"2015","unstructured":"Doni A, Musso T, Morone D, Bastone A, Zambelli V, Sironi M, et al. An acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair mode. J Exp Med. 2015;212(6):905\u201325. https:\/\/doi.org\/10.1084\/jem.20141268.","journal-title":"J Exp Med"},{"issue":"3","key":"617_CR11","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/hep.29215","volume":"66","author":"L Perea","year":"2017","unstructured":"Perea L, Coll M, Sanjurjo L, Blaya D, Taghdouini AE, Rodrigo-Torres D, et al. Pentraxin-3 modulates lipopolysaccharide-induced inflammatory response and attenuates liver injury. Hepatology. 2017;66(3):953\u201368. https:\/\/doi.org\/10.1002\/hep.29215.","journal-title":"Hepatology"},{"issue":"3","key":"617_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MOG.0b013e3283279668","volume":"25","author":"J Jiao","year":"2009","unstructured":"Jiao J, Friedman SL, Aloman C. Hepatic fibrosis. Curr Opin Gastroenterol. 2009;25(3):223\u20139.","journal-title":"Curr Opin Gastroenterol"},{"issue":"3","key":"617_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10238-009-0039-z","volume":"9","author":"M Zanetti","year":"2009","unstructured":"Zanetti M, Bosutti A, Ferreira C, Vinci P, Biolo G, Fonda M, et al. Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile. Clin Exp Med. 2009;9(3):243\u20138. https:\/\/doi.org\/10.1007\/s10238-009-0039-z.","journal-title":"Clin Exp Med"},{"issue":"1","key":"617_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10238-007-0118-y","volume":"7","author":"A Bosutti","year":"2007","unstructured":"Bosutti A, Grassi G, Zanetti M, Aleksova A, Zecchin M, Sinagra G, et al. Relation between the plasma levels of LDL-cholesterol and the expression of the early marker of inflammation long pentraxin PTX3 and the stress response gene p66ShcA in pacemaker-implanted patients. Clin Exp Med. 2007;7(1):16\u201323. https:\/\/doi.org\/10.1007\/s10238-007-0118-y.","journal-title":"Clin Exp Med"},{"issue":"7\u20138","key":"617_CR15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.20452\/pamw.14913","volume":"129","author":"A Trojak","year":"2019","unstructured":"Trojak A, Walus-Miarka M, Kapusta M, Miarka P, Kawalec E, Idzior-Walus B, et al. Serum pentraxin 3 concentration in patients with type 2 diabetes and nonalcoholic fatty liver disease. Pol Arch Intern Med. 2019;129(7\u20138):499\u2013505. https:\/\/doi.org\/10.20452\/pamw.14913.","journal-title":"Pol Arch Intern Med"},{"key":"617_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-230X-8-53","volume":"8","author":"M Yoneda","year":"2008","unstructured":"Yoneda M, Uchiyama T, Kato S, Endo H, Fujita K, Yoneda K, et al. Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH). BMC Gastroenterol. 2008;8:53. https:\/\/doi.org\/10.1186\/1471-230X-8-53.","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"617_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/jvh.12472","volume":"23","author":"RF Carmo","year":"2016","unstructured":"Carmo RF, Aroucha D, Vasconcelos LR, Pereira LM, Moura P, Cavalcanti MS. Genetic variation in PTX3 and plasma levels associated with hepatocellular carcinoma in patients with HCV. J Viral Hepat. 2016;23(2):116\u201322. https:\/\/doi.org\/10.1111\/jvh.12472.","journal-title":"J Viral Hepat"},{"key":"617_CR18","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.15134","author":"J Gorka-Dynysiewicz","year":"2020","unstructured":"Gorka-Dynysiewicz J, Pazgan-Simon M, Zuwala-Jagiello J. Accurate prediction of significant liver fibrosis using the Pentra score model in patients with chronic hepatitis C. Pol Arch Intern Med. 2020. https:\/\/doi.org\/10.20452\/pamw.15134.","journal-title":"Pol Arch Intern Med"},{"issue":"15","key":"617_CR19","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.7150\/jca.25188","volume":"9","author":"T Song","year":"2018","unstructured":"Song T, Wang C, Guo C, Liu Q, Zheng X. Pentraxin 3 overexpression accelerated tumor metastasis and indicated poor prognosis in hepatocellular carcinoma via driving epithelial-mesenchymal transition. J Cancer. 2018;9(15):2650\u20138. https:\/\/doi.org\/10.7150\/jca.25188.","journal-title":"J Cancer"},{"issue":"6","key":"617_CR20","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jmii.2015.12.006","volume":"50","author":"WC Fan","year":"2017","unstructured":"Fan WC, Huang CC, Yang YY, Lin A, Lee KC, Hsieh YC, et al. Serum pentraxin-3 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) predict severity of infections in acute decompensated cirrhotic patients. J Microbiol Immunol Infect. 2017;50(6):905\u201314. https:\/\/doi.org\/10.1016\/j.jmii.2015.12.006.","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"617_CR21","doi-asserted-by":"publisher","first-page":"780","DOI":"10.5604\/01.3001.0010.2789","volume":"16","author":"JL Narciso-Schiavon","year":"2017","unstructured":"Narciso-Schiavon JL, Pereira JG, Silva TE, Bansho ETO, Morato EF, Pinheiro JT, et al. Circulating levels of pentraxin-3 (PTX3) in patients with liver cirrhosis. Ann Hepatol. 2017;16(5):780\u20137. https:\/\/doi.org\/10.5604\/01.3001.0010.2789.","journal-title":"Ann Hepatol"},{"issue":"6","key":"617_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.molmed.2016.04.007","volume":"22","author":"E Magrini","year":"2016","unstructured":"Magrini E, Mantovani A, Garlanda C. The dual complexity of PTX3 in health and disease: a balancing act? Trends Mol Med. 2016;22(6):497\u2013510. https:\/\/doi.org\/10.1016\/j.molmed.2016.04.007.","journal-title":"Trends Mol Med"},{"issue":"1","key":"617_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13046-018-0777-4","volume":"37","author":"F Xu","year":"2018","unstructured":"Xu F, Jin T, Zhu Y, Dai C. Immune checkpoint therapy in liver cancer. J Exp Clin Cancer Res. 2018;37(1):110. https:\/\/doi.org\/10.1186\/s13046-018-0777-4.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"617_CR24","doi-asserted-by":"publisher","first-page":"e0117420","DOI":"10.1371\/journal.pone.0117420","volume":"10","author":"V De Re","year":"2015","unstructured":"De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, et al. Genetic diversity of the KIR\/HLA system and susceptibility to hepatitis C virus-related diseases. PLoS ONE. 2015;10(2):e0117420. https:\/\/doi.org\/10.1371\/journal.pone.0117420.","journal-title":"PLoS ONE"},{"issue":"17","key":"617_CR25","doi-asserted-by":"publisher","first-page":"13666","DOI":"10.18632\/oncotarget.24446","volume":"9","author":"AJ Legrand","year":"2018","unstructured":"Legrand AJ, Poletto M, Pankova D, Clementi E, Moore J, Castro-Giner F, et al. Persistent DNA strand breaks induce a CAF-like phenotype in normal fibroblasts. Oncotarget. 2018;9(17):13666\u201381. https:\/\/doi.org\/10.18632\/oncotarget.24446.","journal-title":"Oncotarget"},{"issue":"7","key":"617_CR26","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1136\/gut.2009.193227","volume":"59","author":"M Rossle","year":"2010","unstructured":"Rossle M, Gerbes AL. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update. Gut. 2010;59(7):988\u20131000. https:\/\/doi.org\/10.1136\/gut.2009.193227.","journal-title":"Gut"},{"issue":"9","key":"617_CR27","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/eci.12122","volume":"43","author":"K Eisinger","year":"2013","unstructured":"Eisinger K, Krautbauer S, Wiest R, Karrasch T, Hader Y, Scherer MN, et al. Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension. Eur J Clin Invest. 2013;43(9):926\u201332. https:\/\/doi.org\/10.1111\/eci.12122.","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"617_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.cyto.2011.06.001","volume":"55","author":"J Wanninger","year":"2011","unstructured":"Wanninger J, Weigert J, Wiest R, Bauer S, Karrasch T, Farkas S, et al. Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function. Cytokine. 2011;55(3):435\u201340. https:\/\/doi.org\/10.1016\/j.cyto.2011.06.001.","journal-title":"Cytokine"},{"issue":"16","key":"617_CR29","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.3390\/ijms20163919","volume":"20","author":"S Feder","year":"2019","unstructured":"Feder S, Kandulski A, Schacherer D, Weiss TS, Buechler C. Serum chemerin does not differentiate colorectal liver metastases from hepatocellular carcinoma. Int J Mol Sci. 2019;20(16):3919. https:\/\/doi.org\/10.3390\/ijms20163919.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"617_CR30","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/oby.20695","volume":"22","author":"A Witasp","year":"2014","unstructured":"Witasp A, Carrero JJ, Michaelsson K, Ahlstrom H, Kullberg J, Adamsson V, et al. Inflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss. Obesity (Silver Spring). 2014;22(5):1373\u20139. https:\/\/doi.org\/10.1002\/oby.20695.","journal-title":"Obesity (Silver Spring)"},{"key":"617_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13028-014-0055-1","volume":"56","author":"O Thomsson","year":"2014","unstructured":"Thomsson O, Strom-Holst B, Sjunnesson Y, Bergqvist AS. Validation of an enzyme-linked immunosorbent assay developed for measuring cortisol concentration in human saliva and serum for its applicability to analyze cortisol in pig saliva. Acta Vet Scand. 2014;56:55. https:\/\/doi.org\/10.1186\/s13028-014-0055-1.","journal-title":"Acta Vet Scand"},{"key":"617_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fneur.2015.00179","volume":"6","author":"U Andreasson","year":"2015","unstructured":"Andreasson U, Perret-Liaudet A, van Waalwijk van Doorn LJ, Blennow K, Chiasserini D, Engelborghs S, et al. A practical guide to immunoassay method validation. Front Neurol. 2015;6:179. https:\/\/doi.org\/10.3389\/fneur.2015.00179.","journal-title":"Front Neurol"},{"issue":"3","key":"617_CR33","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1365-2362.2009.02085.x","volume":"39","author":"R Wiest","year":"2009","unstructured":"Wiest R, Leidl F, Kopp A, Weigert J, Neumeier M, Buechler C, et al. Peritoneal fluid adipokines: ready for prime time? Eur J Clin Invest. 2009;39(3):219\u201329. https:\/\/doi.org\/10.1111\/j.1365-2362.2009.02085.x.","journal-title":"Eur J Clin Invest"},{"issue":"11","key":"617_CR34","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/17474124.2018.1530110","volume":"12","author":"F Tacke","year":"2018","unstructured":"Tacke F, Weiskirchen R. An update on the recent advances in antifibrotic therapy. Expert Rev Gastroenterol Hepatol. 2018;12(11):1143\u201352. https:\/\/doi.org\/10.1080\/17474124.2018.1530110.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"7","key":"617_CR35","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3390\/ijms18071392","volume":"18","author":"C Buechler","year":"2017","unstructured":"Buechler C, Haberl EM, Rein-Fischboeck L, Aslanidis C. Adipokines in Liver Cirrhosis. Int J Mol Sci. 2017;18(7):1392. https:\/\/doi.org\/10.3390\/ijms18071392.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"617_CR36","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1007\/s10620-006-9310-2","volume":"51","author":"M Wadhawan","year":"2006","unstructured":"Wadhawan M, Dubey S, Sharma BC, Sarin SK. Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child\u2019s status. Dig Dis Sci. 2006;51(12):2264\u20139. https:\/\/doi.org\/10.1007\/s10620-006-9310-2.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"617_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12967-017-1154-3","volume":"15","author":"C Graham","year":"2017","unstructured":"Graham C, Chooniedass R, Stefura WP, Lotoski L, Lopez P, Befus AD, et al. Stability of pro- and anti-inflammatory immune biomarkers for human cohort studies. J Transl Med. 2017;15(1):53. https:\/\/doi.org\/10.1186\/s12967-017-1154-3.","journal-title":"J Transl Med"},{"issue":"5","key":"617_CR38","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1161\/01.ATV.0000012282.39306.64","volume":"22","author":"E Napoleone","year":"2002","unstructured":"Napoleone E, Di Santo A, Bastone A, Peri G, Mantovani A, de Gaetano G, et al. Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation. Arterioscler Thromb Vasc Biol. 2002;22(5):782\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"617_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1189\/jlb.1003528","volume":"76","author":"E Napoleone","year":"2004","unstructured":"Napoleone E, di Santo A, Peri G, Mantovani A, de Gaetano G, Donati MB, et al. The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation. J Leukoc Biol. 2004;76(1):203\u20139. https:\/\/doi.org\/10.1189\/jlb.1003528.","journal-title":"J Leukoc Biol"},{"issue":"5","key":"617_CR40","doi-asserted-by":"publisher","first-page":"e0177020","DOI":"10.1371\/journal.pone.0177020","volume":"12","author":"RMW Kremers","year":"2017","unstructured":"Kremers RMW, Kleinegris MC, Ninivaggi M, de Laat B, Ten Cate H, Koek GH, et al. Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis. PLoS ONE. 2017;12(5):e0177020. https:\/\/doi.org\/10.1371\/journal.pone.0177020.","journal-title":"PLoS ONE"},{"issue":"6","key":"617_CR41","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/MBC.0000000000000117","volume":"25","author":"OK Laine","year":"2014","unstructured":"Laine OK, Koskela SM, Outinen TK, Joutsi-Korhonen L, Huhtala H, Vaheri A, et al. Plasma pentraxin-3 and coagulation and fibrinolysis variables during acute Puumala hantavirus infection and associated thrombocytopenia. Blood Coagul Fibrinolysis: Int J Haemost Thrombosis. 2014;25(6):612\u20137. https:\/\/doi.org\/10.1097\/MBC.0000000000000117.","journal-title":"Blood Coagul Fibrinolysis: Int J Haemost Thrombosis"},{"issue":"3","key":"617_CR42","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1600-0897.2012.01158.x","volume":"68","author":"R Boij","year":"2012","unstructured":"Boij R, Svensson J, Nilsson-Ekdahl K, Sandholm K, Lindahl TL, Palonek E, et al. Biomarkers of coagulation, inflammation, and angiogenesis are independently associated with preeclampsia. Am J Reprod Immunol. 2012;68(3):258\u201370. https:\/\/doi.org\/10.1111\/j.1600-0897.2012.01158.x.","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"617_CR43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.bcmd.2010.10.016","volume":"46","author":"E Nur","year":"2011","unstructured":"Nur E, van Beers EJ, Martina S, Cuccovillo I, Otten HM, Schnog JJ, et al. Plasma levels of pentraxin-3, an acute phase protein, are increased during sickle cell painful crisis. Blood Cells Mol Dis. 2011;46(3):189\u201394. https:\/\/doi.org\/10.1016\/j.bcmd.2010.10.016.","journal-title":"Blood Cells Mol Dis"},{"key":"617_CR44","doi-asserted-by":"publisher","first-page":"3295725","DOI":"10.1155\/2019\/3295725","volume":"2019","author":"MJ Valente","year":"2019","unstructured":"Valente MJ, Rocha S, Coimbra S, Catarino C, Rocha-Pereira P, Bronze-da-Rocha E, et al. Long pentraxin 3 as a broader biomarker for multiple risk factors in end-stage renal disease: association with all-cause mortality. Mediat Inflamm. 2019;2019:3295725. https:\/\/doi.org\/10.1155\/2019\/3295725.","journal-title":"Mediat Inflamm"},{"issue":"1","key":"617_CR45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","volume":"60","author":"R Wiest","year":"2014","unstructured":"Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol. 2014;60(1):197\u2013209. https:\/\/doi.org\/10.1016\/j.jhep.2013.07.044.","journal-title":"J Hepatol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-020-00617-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-020-00617-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-020-00617-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T19:45:50Z","timestamp":1613763950000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-020-00617-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,20]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["617"],"URL":"https:\/\/doi.org\/10.1007\/s10238-020-00617-4","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"type":"print","value":"1591-8890"},{"type":"electronic","value":"1591-9528"}],"subject":[],"published":{"date-parts":[[2020,2,20]]},"assertion":[{"value":"16 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The manuscript has not been previously published or submitted in whole or in part elsewhere. All analysis performed in studies involving human plasma\/serum samples were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all patients included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}